|
?:authorAffiliation
|
-
[\'Department of Pharmaceutical & Health Economics, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.\', \'The Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA.\', \'Department of Acute & Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD, USA.\', \'Monument Analytics, Baltimore, MD, USA.\', \'Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}